🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don’t miss research at #ASCO25: This study presented by Dana-Farber later today looks at colon cancer and diet, suggesting diet may influence cancer outcomes after diagnosis and treatment. Press release here: bit.ly/3FobT0z

#ASCO25 👏👏 ⁦Ticiana Batista (Leal)⁩ ⁦Winship Cancer Institute of Emory University⁩ takes it Right Out of the Gate in her discussion of 1L therapy options of Stage IV 🫁 lung cancer abstracts

Dr. Marcelo Corassa, MD. discusses targeted presentations for NSCLC at #ASCO25. Will TKIs overtake amivantamab for #EGFR exon 20 - how do we balance efficacy and safety? In HER2, like T-DXd and zongertinib - sevabertinib has impressive efficacy, but rates of diarrhea high.

🫁 #LungCancer Oral Abstract Session #ASCO25 Comprehensive discussion by Marcelo Corassa, MD. 🇧🇷 on efficacy, safety, and sequencing of novel therapies for HER2 and EGFR Exon 20 ins NSCLC Just like heading to McCormick place all routes / approaches will be needed while balancing

Don’t forget! 🗓️ Submit your abstracts for #ASCOQLTY25 by June 10. A great opportunity to share your work on cancer care delivery, equity, and quality. Let’s keep driving impact together! #ASCO25

Loved reconnecting with Narjust Florez, MD, FASCO and Dr Kathryn Schmitz to celebrate Paulo G Bergerot’s work in exercise oncology! 💪🏽🧬 Grateful for the collaboration and all we’re building together to support patients through science and movement. #ASCO25

🚨 #ASCO25 Newer EGFR-targeted therapies continue to evolve, but optimal sequencing remains a key debate. My yesterday’s interview with Coral Olazagasti, MD on panel discussion by Sandip Patel MD FASCO Narjust Florez, MD, FASCO Oncology Brothers echoed again today—Beyond efficacy, tolerability is key—many

A GREAT DAY 3⃣ of #ASCO25 CURRENT STATS from #MEDTRACK ⚕️ my.medical.watch/oncoalert/hash… These are brought to you by OncoAlert 🚨and Medical.watch THANK YOU ALL FOR THE GREAT ENGAGEMENT Emre Yekedüz gilberto lopes Dr Joseph McCollom DO Dra. María Natalia Gandur Quiroga Bárbara Melão, MD, PhD Oncology Brothers

🔊 Narjust Florez, MD, FASCO is live in the Patient Advocacy Lounge! This powerful panel is diving into the role of patient advocacy in research—from design to implementation. Let’s talk about how advocates can shape research that truly works for you. 💡🧬 Rumor has it that #HearHer pins

📍An #ASCOTradition I love💖: Pictures with the amazing Bergerots Paulo G Bergerot Cristiane D Bergerot 📍Stop by Posters 390 & 395 to hear more about their amazing work on #ExerciseOnc & #GeriOnc in #LATAM #ASCO25

✅️Same high school ✅️Same med school ✅️& now, Same ASCO #ASCO25 Our "education comes first" Ekiti mothers would be so proud! #FlorezLab

Hear her! Great campaign about awareness of lung cancer in women. Gracias ⁦Narjust Florez, MD, FASCO⁩ for the beutiful pin

📍Full house today at the Patient Advocate Lounge with key panelists discussing the key contributions of #patientadvocates to Oncology research & care. 📍A good reminder that at the end of the day, patients & advocates are the most important people in the room #ASCO25 #HearHer

Congratulations 👏🏻👏🏻👏🏻to 🌟Dr Ana Velazquez-Manana🌟 for receiving the Healio Disruptive Innovators Health Equity Award at #ASCO25! 🎉🎉 UCSF Helen Diller Family Comprehensive Cancer Ctr 🔥

🚨 Landmark results from the CHALLENGE trial (NCT00819208): A 3-year structured exercise program post-adjuvant chemo led to significantly better DFS & OS in colon cancer patients vs. education alone Level 1 evidence that #ExerciseOncology matters! #ASCO25 nejm.org/doi/full/10.10…

Double trouble for the Bergerots Paulo G Bergerot Cristiane D Bergerot . 2 poster presentations here ASCO. So impressed by the work you are both doing!

Amazing to share the #HearHer campaign with these amazing patient advocates today here at ASCO . We are inspired by all of you and have learned tremendously from our discussions. We are so thankful to share with you all! There’s still time to get your pin!!!

Thank you for the invitation to our patient advocates/experts to be a speaker in one of their 3 sessions during #ASCO25

New interview loading…… So excited for this interview in English and en Español. We are having so much fun here #FlorezLab #LatinasInMedicine we can’t not have a couple laughs and support our friends Coral Olazagasti, MD Narjust Florez, MD, FASCO #bloopers #goodtimes

One of my favorite parts of #ASCO25 is to connect with women leaders in many oncology subspecialties -Psycho-oncology -Multiple Myeloma - GI - Thoracic oncology Cristiane D Bergerot